Search

everythinglearnresearchcommunity

for

Search:↓

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Medication and hair removal methods can improve hirsutism, but no drugs were specifically approved for it in North America as of 1995.

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

To stop online sexism, both men and women need to change how they act.

Platelet-rich plasma might help with skin aging, ulcers, and hair loss, but more research is needed to prove its effectiveness and safety.

More research is needed to determine if iron deficiency causes hair loss.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

Men prefer less invasive cosmetic procedures and need different treatment approaches than women.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Laser therapy helped new hair grow in scarred skin for three patients.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.